Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,224
datasets available to search
ShareScore release 0.9.0
Dataset results
1,224 results for “1-1”
A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005)
ClinicalTrials.gov study NCT01466985. IPD Sharing: YES. Countries: 0. Publications: 1.
Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
ClinicalTrials.gov study NCT00076843. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patien
ClinicalTrials.gov study NCT00983060. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
ClinicalTrials.gov study NCT00993720. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
ClinicalTrials.gov study NCT01449019. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
ClinicalTrials.gov study NCT01319331. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lacunar Intervention Trial 1 (LACI-1)
ClinicalTrials.gov study NCT02481323. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
ClinicalTrials.gov study NCT01931982. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults
ClinicalTrials.gov study NCT02346084. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected P
ClinicalTrials.gov study NCT04006704. IPD Sharing: YES. Countries: 2. Publications: 1.
Mobile Application-delivered Resistance Program for Children and Adolescents With Type 1 Diabetes (Diactive-1)
ClinicalTrials.gov study NCT06048757. IPD Sharing: NO. Countries: 1. Publications: 1.
The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
ClinicalTrials.gov study NCT00004984. IPD Sharing: YES. Countries: 2. Publications: 7.
A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.
ClinicalTrials.gov study NCT01466322. IPD Sharing: YES. Countries: 1. Publications: 4.
A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)
ClinicalTrials.gov study NCT05766501. IPD Sharing: YES. Countries: 15. Publications: 0.
ONE-1 Oral graNd Est 1
ClinicalTrials.gov study NCT05089214. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT03468751. IPD Sharing: NO. Countries: 1. Publications: 1.
Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)
ClinicalTrials.gov study NCT02403674. IPD Sharing: YES. Countries: 0. Publications: 9.
A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients
ClinicalTrials.gov study NCT00089492. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
ClinicalTrials.gov study NCT02355535. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.
ClinicalTrials.gov study NCT02736552. IPD Sharing: Not stated. Countries: 1. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.